Cargando…
Pre-Treatment Hemoglobin Concentration and Absolute Monocyte Count as Independent Prognostic Factors for Survival in Localized or Locally Advanced Prostate Cancer Patients Undergoing Radiotherapy
The prognostic value of inflammatory indices, such as the absolute monocyte count (AMC), has been a subject of interest in recent prostate cancer (PCa) studies, while hemoglobin concentration (HGB) has been recognized as a survival factor in castration-resistant metastatic prostate cancer, but its v...
Autores principales: | Magrowski, Łukasz, Masri, Oliwia, Ciepał, Jakub, Depowska, Gabriela, Nowicka, Zuzanna, Stando, Rafał, Chimiak, Krystyna, Bylica, Gabriela, Czapla, Barbara, Masri, Małgorzata, Cichur, Franciszek, Jabłońska, Iwona, Gmerek, Marta, Wojcieszek, Piotr, Krzysztofiak, Tomasz, Sadowski, Jacek, Suwiński, Rafał, Rajwa, Paweł, Moll, Matthias, Goldner, Gregor, Majewski, Wojciech, Miszczyk, Marcin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599626/ https://www.ncbi.nlm.nih.gov/pubmed/36289778 http://dx.doi.org/10.3390/biomedicines10102514 |
Ejemplares similares
-
Prostate-specific antigen kinetics and metastasis-free survival in patients treated with external beam radiotherapy combined with high-dose-rate brachytherapy boost and androgen deprivation therapy for localized prostate cancer
por: Miszczyk, Marcin, et al.
Publicado: (2022) -
Prognostic Factors in Postoperative Radiotherapy for Prostate Cancer – Tertiary Center Experience
por: Miszczyk, Marcin, et al.
Publicado: (2021) -
Rectum and Bladder Toxicity in Postoperative Prostate Bed Irradiation: Dose–Volume Parameters Analysis
por: Hasterok, Maja, et al.
Publicado: (2023) -
Long-Term Outcomes of Stereotactic Body Radiotherapy (SBRT) for Intraprostatic Relapse after Definitive Radiotherapy for Prostate Cancer: Patterns of Failure and Association between Volume of Irradiation and Late Toxicity
por: Miszczyk, Marcin, et al.
Publicado: (2023) -
Ultra-Hypofractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer: Clinical Outcomes, Patterns of Recurrence, Feasibility of Definitive Salvage Treatment, and Competing Oncological Risk
por: Miszczyk, Marcin, et al.
Publicado: (2022)